Thread

Conversation

Let me me perfectly clear about the evidence for myocarditis after mRNA vaccines 1. There is a notable increased incidence, age 12-39, males, with each dose (Table) acpjournals.org/doi/10.7326/M2

3:45 PM · Oct 12, 2022Twitter Web App

Replying to

2. It is usually mild, with complete recovery in most thelancet.com/journals/lanch

bmj.com

Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericard...

Objectives To synthesise evidence on incidence rates and risk factors for myocarditis and pericarditis after use of mRNA vaccination against covid-19, clinical presentation, short term and longer...

585

Eric Topol

@EricTopol

Oct 12

3. There are NO credible data linking this adverse effect with cardiac deaths, despite a flawed widely disseminated Florida study based on 20 deaths washingtonpost.com/health/2022/10

@ddiamond

Breakdown of multiple, systematic flaws

Quote Tweet

Kristen Panthagani, MD, PhD

@kmpanthagani

Oct 9

Florida just announced the results of an analysis that they performed, saying the results show "an increased risk of cardiac-related death among men 18-39" for the mRNA vaccines, and recommend this group not receive these vaccines. Is this justified? Let's look at the data...

Show this thread

196

916

Replying to

Thank you!

Replying to

and

Not enough time has passed to know that recovery is complete. There may be ongoing or future heart issues, and to know this requires at least 5 years data. There is no long term data supporting his claim. This meets the usual standard of “science” applied in this pandemic.

Show replies

Replying to

Any studies on people in their 50’s & 60’s, male & female?

Replying to

So if true how can Universities continue to mandate young men get boosters?

Replying to

and

Because it’s mild and resolves on its own.

Show replies

Replying to

Do you by chance have updated comparable data on incidence of myocarditis following infection with corona?

Replying to

Hast du das schon gesehen?

Replying to

and

Ja klar, Inzidenz vax-Myocarditis ist deutlich geringer als Kardiovaskuläre Krankheiten und Tod nach (long) #SARSCoV2. Keep on spreading the virus, totally scientific

Replying to

Dear Eric That should make you pause. Go for a run, clear your mind, and reconsider current public health policy in light of this admission. Young men will thank you.

Show replies

Replying to

Aw, well as long as it’s only mild myocarditis, let’s keep forcing young healthy college students to take a vaccine they don’t need.

Replying to

and

When they go live in a dorm or frat house, they will most likely get Covid, which carries a much greater risk of myocarditis than the vaccine. Plus, getting Covid unvaccinated comes with plenty of other risks above and beyond the tiny risk of the vaccine.

Replying to

It's important to be open & honest about these incidents. The rate is higher than many talked about for booster. I remember some talking like the rate for booster was lower than dose 1, which has turned out not to be true. "Most" are mild. One study show some not recovered.

Replying to

and

It would be really great we can solve this problem or have honest discussions on the risk benefit calculations for these age groups.

Replying to

Is it possible that the same incidence in women is missed because women’s symptoms are not taken seriously, so they never get to the stage where it is identified? Asking based on past personal experience with myocarditis that was only discovered after extensive advocacy.

140

Replying to

and

* Mine was not vaccine-related, to be clear. This was years ago.

Show replies

Replying to

Appreciate this. You forgot to add: 4) The risk of myocarditis is far higher if you get exposed the spike protein via infection, than if you get exposed via vaccination.

heart.org

COVID-19 infection poses higher risk for myocarditis than vaccines

The overall risk of myocarditis was higher immediately after being infected with COVID-19 than in the weeks after vaccination for the coronavirus, new research shows.

128

989

Replying to

Thank you for the data♧

Replying to

Incidence rate actually goes

for 3rd dose (vs 2nd dose) for everyone except 16-17 year olds (both male and female - altho of course F have lower rates). Note: it’s likely that 3rd dose has higher rates even for older teens, early 20s? But data is too coarse to allow knowing.

Replying to

and

Males 12-39 have negligible risk of serious illness from Covid so why would a govt recommend (or worse mandate) a Covid vaccine which has a notable incidence of myocarditis (with sometimes serious/unrecoverable effects) for that group? First, do no harm.

Replying to

and

“Negligible risk”? Males 30-39 had a case fatality rate around 0.5% prior to vaccines being available. Don’t forget the reason COVID is largely “not that bad” now is *because of vaccination*

ncbi.nlm.nih.gov

Subgroup comparison of COVID-19 case and mortality with associated factors in Mississippi: findings...

We compared subgroup differences in COVID-19 case and mortality and investigated factors associated with case and mortality rate (MR) measured at the county level in Mississippi. Findings were based...

Show replies

Peter Billing, MD FACS

@PBillingMD

Oct 12

Replying to

@EricTopol

It might be a good idea to let patients decide since there’s controversy.

Replying to

and

Or perhaps we should just properly give our patients informed consent like we are supposed to do, & reassure them that the vaccines are safe.

Show replies

Replying to

I would probably want my son or spouse in that age range to get Novovax, even though the risk is mild.

Replying to

and

Myocarditis and pericarditis were also seen with Novavax.

Show replies

Replying to

Great

Eric. Also important to mention that increasing the time between 1st and 2nd dose from 4 weeks to 8 - 12 significantly

risk of myocarditis in young men.

277

Replying to

and

It really annoys me that we haven’t spoken about or studied this more. Increasing length of time between doses may both

risk of side effects (like myocarditis) and increase robustness and duration of immunity. But we seem to be locked into 30 days…

280

Show replies

Replying to

i'm in that demographic group and got this after the updated booster. the symptoms went away after 5/6 days, but the first few were scary. the shots were overall worth it, because i never got covid despite going out/traveling internationally. probably won't get another shot.

Replying to

Thank you

for, as

would say, "calling balls & strikes". For those of us who understand, that's all we need.

Replying to

Was the Danish government decision based on this finding or was it on cost effectiveness ?

Christian Bernhard Hagen

Replying to

and

They didn't and don't want to tell. Not even when pressed by international capacities like Kristian G Andersen.

Replying to

What about 12-15yo after Pfizer dose 2 and booster? Even higher incidence that 18-30yo. And any data on Moderna 12-15yo, since it’s 18-30yo is much higher, I’m kinda afraid to ask see the data for 12-15 (my 11-12yo son was in the Moderna Kid Cove trial).